Glutamine addiction in tumor cell: oncogene regulation and clinical treatment

Xian Li1, Xueqiang Peng1, Yan Li1

  • 1Department of General Surgery, The Fourth Affiliated Hospital, China Medical University, Shenyang, 110032, China.

Insights

Targeting cancer cell glutamine metabolism is a promising strategy. This review details glutamine

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Biochemistry

Background:

  • Tumor cells reprogram metabolism, increasing glutamine consumption for proliferation.
  • Glutamine metabolism is crucial for cancer cell survival and progression.

Purpose of the Study:

  • To review glutamine metabolism in tumor cells.
  • To explore its role in biosynthesis and cancer development.
  • To assess anti-cancer agents targeting glutamine metabolism.

Main Methods:

  • Literature review of glutamine metabolism in cancer.
  • Summary of oncogene regulation (C-MYC, KRAS, HIF, p53) on glutamine metabolism.
  • Analysis of glutamine's role in mTORC1 activation.

Main Results:

  • Glutamine fuels biosynthesis of amino acids, nucleotides, and fatty acids.
  • Oncogenes significantly regulate glutamine metabolism.
  • Glutamine activates mTORC1 signaling pathway.

Conclusions:

  • Targeting glutamine metabolism offers a viable anti-cancer strategy.
  • Understanding glutamine's role is key for developing new cancer therapies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K